Related Experiment Video

Updated: Apr 27, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

12.2K

Antitumor activity of G-quadruplex-interactive agent TMPyP4 with photodynamic therapy in ovarian carcinoma cells

Hongli Liu1, Changshuai Lv1, Baijuan Ding1

  • 1Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China.

Oncology Letters
|June 25, 2014
PubMed

Insights

Photodynamic therapy (PDT) using 5,10,15,20-tetra-(N-methyl-4-pyridyl)porphine (TMPyP4) effectively inhibited ovarian carcinoma cell growth. This therapy induced apoptosis and reduced metastasis by downregulating MCM2 and CA-IX expression.

Area of Science:

  • Oncology
  • Photochemistry
  • Cell Biology

Background:

  • Ovarian carcinoma remains a significant health challenge with limited treatment options.
  • Photodynamic therapy (PDT) offers a targeted approach for cancer treatment.
  • Cationic porphyrins are photosensitizers with potential in PDT.

Purpose of the Study:

  • To investigate the efficacy of TMPyP4-mediated PDT against ovarian carcinoma cells.
  • To elucidate the underlying molecular mechanisms of TMPyP4-PDT action.
  • To assess the potential of TMPyP4-PDT as a therapeutic strategy for ovarian cancer.

Main Methods:

  • Ovarian carcinoma cell line (A2780) treatment with TMPyP4 and laser irradiation.
  • Assessment of cell viability, proliferation, and motility.
  • Flow cytometry for apoptosis analysis.
  • Western blot to detect MCM2 and CA-IX expression levels.

Main Results:

  • TMPyP4-PDT significantly suppressed A2780 cell growth in a dose- and laser energy-dependent manner.
  • PDT treatment inhibited cell proliferation and motility.
  • TMPyP4-PDT induced apoptosis and reduced metastasis, correlated with decreased MCM2 and CA-IX expression.

Conclusions:

  • TMPyP4-PDT demonstrates potent anti-cancer effects on ovarian carcinoma cells.
  • The mechanism involves induction of apoptosis and inhibition of proliferation, motility, MCM2, and CA-IX.
  • TMPyP4-PDT presents a promising therapeutic avenue for ovarian carcinoma treatment.
Keywords:
5,10,15,20-tetra-(N-methyl-4-pyridyl) porphinecarbonic anhydrase IXhuman ovarian carcinomaminichromosome maintenance protein-2photodynamic therapy

More Related Videos

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

2.8K
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids06:25

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Published on: June 14, 2021

6.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K